Nexbiotek, launched in 2024, is a new brand from Novascope Diagnostics Inc., aiming to provide high quality and economic recombinant protein/antibody reagents for research studies. Founded in 2022, Novascope is pioneering the next generation of diagnostics platform to reach the targets of early diagnosis & timely treatments.